What You Should Know
– Teal Health, the creator of the first FDA-authorized self-collection device for cervical cancer screening, has launched its services on the Thatch Marketplace. This partnership allows employees to use tax-free healthcare dollars (via ICHRA) to purchase at-home screening kits, bypassing the traditional clinic visit.
– The move targets the “working age” gap in cancer prevention, where 1 in 3 U.S. women are currently overdue for screening due to time constraints or discomfort.
Teal Health Brings FDA-Authorized Home Screening to Employee Benefits
For decades, the cervical cancer screening experience has remained unchanged: a clinic appointment, a speculum, and often, significant discomfort. Today, Teal Health is moving that experience into the home—and into the corporate benefits package. Teal Health announced today that its virtual women’s health platform and FDA-authorized “Teal Wand” are now available on the Thatch Marketplace. Thatch, a modern benefits platform, enables employers to offer personalized healthcare through Individual Coverage Health Reimbursement Arrangements (ICHRAs). This integration means that for the first time, employees can easily use their employer-provided, tax-free health allowance to access a remote, clinical-grade alternative to the traditional OB-GYN visit.
Solving the “Working Years” Gap
Cervical cancer is unique in the oncology landscape because screenings span 40 years—almost the entirety of a woman’s typical working life. Despite being preventable with routine screening, incidence rates are rising among young, working-aged women. The barriers are logistical and physical. “Today, due to a lack of time, access, and discomfort with the traditional speculum exam, nearly 1 in 3 U.S. women are not up-to-date on their cervical cancer screening,” the company noted.
By moving the screening to an at-home model, Teal Health aims to close this gap. Early data suggests the strategy is working: more than 50% of Teal’s early patients were overdue for screening, and nearly 20% had never been screened before.
How the Tech Works: The Teal Wand
The core of Teal Health’s offering is the Teal Wand™, the first and only FDA-authorized device for vaginal self-collection. The process combines telehealth with hardware:
- Telehealth Prescription: A woman orders a kit and completes a brief virtual visit with a provider.
- Self-Collection: The user collects their own sample at home using the Teal Wand.
- Lab Testing: The sample is mailed to a lab and tested for HPV using the same FDA-approved diagnostics found in clinics.
- Virtual Follow-up: Results are delivered via a secure portal. If high-risk results are found, a provider connects virtually to coordinate next steps.
Crucially, the American Cancer Society’s 2025 guidelines now include this method as an accurate alternative to in-person exams.
The ICHRA Connection: Why Thatch Matters
The partnership with Thatch represents a shift in how “niche” health tech is funded. Thatch uses an ICHRA model, which decouples insurance from the employer. Instead of buying a one-size-fits-all plan, employers give employees tax-free dollars to buy the care they want.
This model is critical for adoption. It allows employees to “vote with their dollars” for innovative preventive care without waiting for traditional insurance carriers to universally cover new devices. “Employees can use tax-free dollars for new preventive care innovations that fit their schedule and preferences,” the announcement states.
“Women want care that is simple, private, and built around their real lives,” said Kara Egan, CEO and Co-founder of Teal Health. “This partnership makes that possible for even more employees.”
